Clinical features and risk factors for the severity of inpatients with COVID-19: a retrospective cohort study

X Zheng, J Chen, L Deng, Z Fang, G Chen… - Available at SSRN …, 2020 - papers.ssrn.com
Background: Coronavirus disease 2019 (COVID-19) have become a pandemic in the world
since it was found and caused an outbreak on December, 2019, Wuhan, China, caused by …

A comparative study of the laboratory features of COVID‐19 and other viral pneumonias in the recovery stage

G Zhao, Y Su, X Sun, X Cui, L Dang… - Journal of clinical …, 2020 - Wiley Online Library
Background Clinical recovery does not mean full recovery. It is necessary to explore the
aftereffects of COVID‐19 in patients and compare the laboratory features of COVID‐19 and …

Mild-to-moderate COVID-19 convalescents may present pro-longed Endothelium Injury

P Kozłowski, M Śmiarowski, W Przyborska… - Journal of clinical …, 2022 - mdpi.com
Background: The SARS-CoV-2 pandemic posed a great threat to public health, healthcare
systems and the economy worldwide. It became clear that, in addition to COVID-19 and …

Temporal changes in laboratory markers of survivors and non-survivors of adult inpatients with COVID-19

SM Ouyang, HQ Zhu, YN Xie, ZS Zou, HM Zuo… - BMC infectious …, 2020 - Springer
Abstract Background Coronavirus disease 2019 (COVID-19) is caused by severe acute
respiratory syndrome coronavirus 2, and outbreaks have occurred worldwide. Laboratory …

Circulating Cytokines and Lymphocyte Subsets in Patients Who Have Recovered from COVID‐19

Hasichaolu, X Zhang, X Li, X Li… - BioMed research …, 2020 - Wiley Online Library
To investigate the immune status of people who previously had COVID‐19 infections, we
recruited two‐week postrecovery patients and analyzed circulating cytokine and lymphocyte …

COVID-19 and the effects on pulmonary function following infection: a retrospective analysis

KL Lewis, SA Helgeson, MM Tatari, JM Mallea… - …, 2021 - thelancet.com
Background The coronavirus disease 2019 (COVID-19) has been identified in over 110
million people with no studies comparing pre-infection pulmonary function to post-infection …

Prediction of adverse clinical outcomes in patients with coronavirus disease 2019

S Shi, X Liu, J Xiao, H Wang, L Chen… - Journal of Clinical …, 2021 - Wiley Online Library
Objective This study aims to investigate blood and biochemical laboratory findings in
patients with coronavirus disease (COVID‐19) and analyze the potential predictors of poor …

Hematological abnormalities and comorbidities are associated with COVID-19 severity among hospitalized patients: experience from Bangladesh

MA Rahman, Y Shanjana, MI Tushar, T Mahmud… - PLoS …, 2021 - journals.plos.org
Background The hematological abnormalities are assumed to be involved in the disease
progression of COVID-19. However, the actual associations between specific blood …

Organ function biomarker abnormalities, associated factors and disease outcome among hospitalized patients with COVID-19

S Araya, YG Tsegay, A Atlaw, M Aragaw… - Biomarkers in …, 2022 - Taylor & Francis
Background: The aim of this study was to determine the magnitude of abnormal organ
function tests and biomarkers in hospitalized patients with confirmed COVID-19 and to …

Effect of Respiratory Failure on Peripheral and Organ Perfusion Markers in Severe COVID-19: A Prospective Cohort Study

M Gutowski, J Klimkiewicz, B Rustecki… - Journal of Clinical …, 2024 - mdpi.com
Microvascular dysfunction and inflammation caused by COVID-19 disrupt organ function.
The study aimed to investigate the association between the severity of SARS-CoV-2 …